Table 2 Characteristics related to psychoactive substance use according to post-HCV cure reduction in cannabis use (cross-sectional survey nested in the ANRS CO13 HEPAVIH cohort, n = 140)
Variable | Total | Reduction in cannabis use after HCV cure | ||
|---|---|---|---|---|
Yes | No | p-value1 | ||
Reason for using cannabis (n = 126) | 0.324 | |||
Therapeutic | 51 (40.5) | 16 (34.8) | 35 (43.8) | |
Recreational only | 75 (59.5) | 30 (65.2) | 45 (56.3) | |
Recent substance injection2 | 0.454 | |||
No | 139 (99.3) | 50 (100.0) | 89 (98.9) | |
Yes | 1 (0.7) | 0 (0.0) | 1 (1.1) | |
Cannabis dependence (n = 129)3 | 0.904 | |||
No risk | 64 (49.6) | 22 (48.9) | 42 (50.0) | |
Low risk | 65 (50.4) | 23 (51.1) | 42 (50.0) | |
High risk | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Opioid substitution therapy (n = 133) | 0.462 | |||
No | 107 (80.5) | 37 (77.1) | 70 (82.4) | |
Current therapy | 26 (19.6) | 11 (22.9) | 15 (17.7) | |
Cannabis use frequency (n = 126) | < 0.001 | |||
Never | 6 (4.8) | 6 (13.0) | 0 (0.0) | |
Sometimes | 51 (40.5) | 29 (63.0) | 22 (27.5) | |
Regularly or daily | 69 (54.8) | 11 (23.9) | 58 (72.5) | |
Other substance use4 | 0.041 | |||
No | 127 (90.7) | 42 (84.0) | 85 (94.4) | |
One or more | 13 (9.3) | 8 (16.0) | 5 (5.6) | |
AUDIT-C score | 2.5 [0–5] | 2 [0–4] | 3 [0–5] | 0.245 |
Alcohol use5 | 0.068 | |||
Not at risk | 78 (55.7) | 33 (66.0) | 45 (50.0) | |
At risk | 62 (44.3) | 17 (34.0) | 45 (50.0) | |
Tobacco use (n = 138) | 0.001 | |||
No current use | 19 (13.8) | 11 (22.9) | 8 (8.9) | |
1 to 5 cig/d | 32 (23.2) | 17 (35.4) | 15 (16.7) | |
6 to 10 cig/d | 41 (29.7) | 12 (25.0) | 29 (32.2) | |
More than 10 cig/d | 46 (33.3) | 8 (16.7) | 38 (42.2) | |